Art. 2 Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…

In forcesince 28 Jan 2022cited 8×

The definitions laid down in Article 1 of Directive 2001/83/EC shall apply for the purposes of this Regulation.

As a consequence, in this Regulation, the terms, ‘medicinal product’ and ‘medicinal product for human use’ mean a medicinal product as defined in point (2) of Article 1 of Directive 2001/83/EC.

In addition, the following definitions shall apply for the purposes of this Regulation:

(1)

‘veterinary medicinal product’ means a medicinal product as defined in point (1) of Article 4 of Regulation (EU) 2019/6 of the European Parliament and of the Council [Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (OJ L 4, 7.1.2019, p. 43).] ;

(2)

‘antimicrobial’ means an antimicrobial as defined in point (12) of Article 4 of Regulation (EU) 2019/6.

The holder of a marketing authorisation for medicinal products covered by this Regulation must be established in the Union. The holder shall be responsible for the placing on the market of those medicinal products, whether he does it himself or via one or more persons designated to that effect.

  • Commission Regulation (EC) No 658/2007 of 14 June 2007 concerning financial penalties fo…1Law

    … indésirable sur l’être humain et toute présomption de transmission d’un agent infectieux, conformément à l’article 49, paragraphes 1, et 2, du règlement (CE) no 726/2004; 18) l’obligation de tenir des rapports détaillés sur …

  • Regulation (EU) 2019/5Lawamends

  • Order of the Court (Ninth Chamber) of 3 June 2015. The Sunrider Corporation v Office for Harmonisation in the Internal Market (Trade Marks aDecision

    … on three grounds of appeal, the first alleging an infringement of point 2 of Article 1 of Directive 2001/83 and of Article 2 of Regulation No 726/2004; the second alleging an infringement of the right to be heard; and the third, which is …

    3 Jun 2015 · 62014CO0142

  • Regulation (EU) 2023/11822Law

    … на настоящия регламент се прилагат определенията, установени в член 2 от Регламент (ЕО) № 726/2004, включително определенията, …

  • Commission Regulation (EU) No 488/2012 of 8 June 2012 amending Regulation (EC) No 658/20…1Law

    … indésirable sur l’être humain et toute présomption de transmission d’un agent infectieux, conformément à l’article 49, paragraphes 1, et 2, du règlement (CE) no 726/2004; 18) l’obligation de tenir des rapports détaillés sur …

  • Opinion of Advocate General Sharpston delivered on 31 January 2013. Novartis Pharma GmbH v Apozyt GmbH.Decision

    By virtue of Article 2, the definitions specified in Article 1 of the Directive are to apply for the purposes of the Regulation.

    31 Jan 2013 · 62011CC0535

  • Opinion of Advocate General Sharpston delivered on 22 April 2010. European Commission v Republic of Lithuania.Decision

    Article 2 of Regulation No 726/2004 provides that ‘... [t]he holder of a marketing authorisation for medicinal products covered by this Regulation must be established in the Community’.

    22 Apr 2010 · 62008CC0350

  • Arrêt du Tribunal (cinquième chambre) du 23 septembre 2026 (Extraits). Advanz Pharma Ltd contre Commission européenne.Decision

    … Similarly, Article 2 of Regulation No 726/2004, as amended by Regulation 2019/5, refers to that definition.

    23 Sep 2026 · 62024TJ0455